Black Rock Inc. Frequency Therapeutics, Inc. Transaction History

Black Rock Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.35 - $0.72 $19,045 - $39,179	-54,416 Reduced 4.45%	1,169,675 $432,000
Q2 2023 Aug 11, 2023	SELL	$0.33 - $0.48 $24,693 - $35,917	-74,829 Reduced 5.76%	1,224,091 $428,000
Q1 2023 May 12, 2023	SELL	$0.44 - $5.47 $53,238 - $661,848	-120,996 Reduced 8.52%	1,298,920 $649,000
Q4 2022 Feb 13, 2023	SELL	$1.88 - $3.85 $524,160 - $1.07 Million	-278,809 Reduced 16.41%	1,419,916 $5.47 Million
Q3 2022 Nov 14, 2022	SELL	$1.46 - $2.55 $56,328 - $98,381	-38,581 Reduced 2.22%	1,698,725 $3.04 Million
Q2 2022 Aug 12, 2022	SELL	$1.03 - $2.03 $1.61 Million - $3.18 Million	-1,564,492 Reduced 47.38%	1,737,306 $2.61 Million
Q1 2022 May 12, 2022	BUY	$1.7 - $5.72 $436,561 - $1.47 Million	256,801 Added 8.43%	3,301,798 $7 Million
Q4 2021 Feb 10, 2022	SELL	$4.95 - $7.11 $726,927 - $1.04 Million	-146,854 Reduced 4.6%	3,044,997 $15.6 Million
Q3 2021 Nov 09, 2021	BUY	$6.96 - $9.25 $842,821 - $1.12 Million	121,095 Added 3.94%	3,191,851 $22.5 Million
Q2 2021 Aug 11, 2021	BUY	$8.05 - $11.61 $24.7 Million - $35.7 Million	3,070,756 New	3,070,756 $30.6 Million

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.